Frataxin mRNA isoforms in FRDA patients and normal subjects: Effect of tocotrienol supplementation

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Abruzzo, Provvidenza Maria ^a   Marini, Marina ^a   Bolotta, Alessandra ^a   Malisardi, Gemma ^b   Manfredini, Stefano ^b   Ghezzo, Alessandro ^a,c   Pini, Antonella ^d   Tasco, Gianluca ^e   Casadio, Rita ^e  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c ANFFAS ONLUS Macerata   (Italy)

^d IRCCS ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA   (Italy)

^e CIRI Health Sciences and Technologies   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOTRIENOL; FRATAXIN; FRATAXIN 1; FRATAXIN 2; FRATAXIN 3; IDEBENONE; IRON; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RNA ISOFORM; SULFUR; UNCLASSIFIED DRUG; COMPLEMENTARY DNA; IRON BINDING PROTEIN; LYASE; NFS1 PROTEIN, HUMAN;

ARTICLE; BLOOD CELL; FRIEDREICH ATAXIA; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; VITAMIN SUPPLEMENTATION; AMINO ACID SEQUENCE; CASE CONTROL STUDY; CHEMISTRY; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR DOCKING; MOLECULAR GENETICS; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; CARBON-SULFUR LYASES; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; DNA, COMPLEMENTARY; FRIEDREICH ATAXIA; GENE EXPRESSION REGULATION; HUMANS; IRON-BINDING PROTEINS; MOLECULAR DOCKING SIMULATION; MOLECULAR SEQUENCE DATA; PPAR GAMMA; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA ISOFORMS; TOCOTRIENOLS;

EID: 84885651917     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/276808     Document Type: Article

References (42)

1. Delatycki M. B., Williamson R., Forrest S. M., Friedreich ataxia: an overview. Journal of Medical Genetics 2000 37 1 1 8 2-s2.0-0034096608 (Pubitemid 30245868)
2. de Michele G., Perrone F., Filla A., Mirante E., Giordano M., De Placido S., Campanella G., Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich's disease: a retrospective study on 119 patients. Neurology 1996 47 5 1260 1264 2-s2.0-0029961968 (Pubitemid 26374897)
3. Gellera C., Castellotti B., Mariotti C., Mineri R., Seveso V., DiDonato S., Taroni F., Frataxin gene point mutations in Italian friedreich ataxia patients. Neurogenetics 2007 8 4 289 299 2-s2.0-35448993553 10.1007/s10048-007- 0101-5 (Pubitemid 47624448)
4. Campuzano V., Montermini L., Moltò M. D., Pianese L., Cossée M., Cavalcanti F., Monros E., Rodius F., Duclos F., Monticelli A., Zara F., Cañizares J., Koutnikova H., Bidichandani S. I., Gellera C., Brice A., Trouillas P., de Michele G., Filla A., De Frutos R., Palau F., Patel P. I., Di Donato S., Mandel J., Cocozza S., Koenig M., Pandolfo M., Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996 271 5254 1423 1427 2-s2.0-13344270899 (Pubitemid 26089479)
5. Pianese L., Turano M., Lo Casale M. S., de Biase I., Giacchetti M., Monticelli A., Criscuolo C., Filla A., Cocozza S., Real time PCR quantification of frataxin mRNA in the peripheral blood leucocytes of friedreich ataxia patients and carriers. Journal of Neurology, Neurosurgery and Psychiatry 2004 75 7 1061 1063 2-s2.0-3042713271 10.1136/jnnp.2003.028605 (Pubitemid 38869629)
6. Pianese L., Tammaro A., Turano M., de Biase I., Monticelli A., Cocozza S., Identification of a novel transcript of X25, the human gene involved in friedreich ataxia. Neuroscience Letters 2002 320 3 137 140 2-s2.0-0037040489 10.1016/S0304-3940(02)00048-4 (Pubitemid 34164434)
7. Xia H., Cao Y., Dai X., Marelja Z., Zhou D., Mo R., Al-Mahdawi S., Pook M. A., Leimkühler S., Rouault T. A., Li K., Novel frataxin isoforms may contribute to the pathological mechanism of friedreich ataxia. PLoS ONE 2012 7 10 e47847 10.1371/journal.pone.0047847
8. Sirano D., Shigeta R., Chi Y., Ristow M., Shoelson S. E., Crystal structure of human frataxin. The Journal of Biological Chemistry 2000 275 40 30753 30756 2-s2.0-0034613233
9. He Y., Alam S. L., Proteasa S. V., Zhang Y., Lesuisse E., Dancis A., Stemmler T. L., Yeast frataxin solution structure, iron binding, and ferrochelatase interaction. Biochemistry 2004 43 51 16254 16262 2-s2.0-11144265730 10.1021/bi0488193 (Pubitemid 40041038)
10. Nair M., Adinolfi S., Pastore C., Kelly G., Temussi P., Pastore A., Solution structure of the bacterial frataxin ortholog, CyaY: mapping the iron binding sites. Structure 2004 12 11 2037 2048 2-s2.0-7944225865 10.1016/j.str.2004.08.012 (Pubitemid 39469401)
11. Bulteau A. L., O'Neill H. A., Kennedy M. C., Ikeda-Saito M., Isaya G., Szweda L. I., Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science 2004 305 5681 242 245 2-s2.0-3042763187 10.1126/science.1098991 (Pubitemid 38886737)
12. Stehling O., Elsässer H., Brückel B., Mühlenhoff U., Lill R., Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Human Molecular Genetics 2004 13 23 3007 3015 2-s2.0-9744248303 10.1093/hmg/ddh324 (Pubitemid 39585233)
13. Adinolfi S., Iannuzzi C., Prischi F., Pastore C., Iametti S., Martin S. R., Bonomi F., Pastore A., Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS. Nature Structural and Molecular Biology 2009 16 4 390 396 2-s2.0-64049116040 10.1038/nsmb.1579
14. Schmucker S., Martelli A., Colin F., Page A., Wattenhofer-Donzé M., Reutenauer L., Puccio H., Mammalian frataxin: an essential function for cellular viability through an interaction with a preformed ISCU/ NFS1/ISD11 iron-sulfur assembly complex. PLoS ONE 2011 6 1 2-s2.0-79551514731 10.1371/journal.pone.0016199 e16199
15. Gakh O., Park S., Liu G., Macomber L., Imlay J. A., Ferreira G. C., Isaya G., Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. Human Molecular Genetics 2006 15 3 467 479 2-s2.0-31544445770 10.1093/hmg/ddi461 (Pubitemid 43159898)
16. Santos R., Lefevre S., Sliwa D., Seguin A., Camadro J. M., Lesuisse E., Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities. Antioxidants and Redox Signaling 2010 13 5 651 690 2-s2.0-77954930779 10.1089/ars.2009.3015
17. Meier T., Buyse G., Idebenone: an emerging therapy for friedreich ataxia. Journal of Neurology 2009 256 1 25 30 2-s2.0-62549120780 10.1007/s00415-009- 1005-0
18. Lagedrost S. J., Sutton M. S. J., Cohen M. S., Satou G. M., Kaufman B. D., Perlman S. L., Rummey C., Meier T., Lynch D. R., Idebenone in friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA). The American Heart Journal 2011 161 3 639 645 2-s2.0-79952451186 10.1016/j.ahj.2010.10.038
19. Lynch D. R., Perlman S. L., Meier T., A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia. Archives of Neurology 2010 67 8 941 947 2-s2.0-77955450939 10.1001/archneurol.2010.168
20. Jauslin M. L., Meier T., Smith R. A., Murphy M. P., Mitochondria-targeted antioxidants protect friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. The FASEB Journal 2003 17 13 1972 1974
21. Nachbauer W., Hering S., Seifert M., Steinkellner H., Sturm B., Scheiber-Mojdehkar B., Reindl M., Strasak A., Poewe W., Weiss G., Boesch S., Effects of erythropoietin on frataxin levels and mitochondrial function in friedreich ataxia-a dose-response trial. Cerebellum 2011 10 4 763 769 2-s2.0-84855941558 10.1007/s12311-011-0287-9
22. Boesch S., Sturm B., Hering S., Goldenberg H., Poewe W., Scheiber-Mojdehkar B., Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin. Annals of Neurology 2007 62 5 521 524 2-s2.0-37349059308 10.1002/ana.21177 (Pubitemid 350308777)
23. Aggarwal B. B., Sundaram C., Prasad S., Kannappan R., Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochemical Pharmacology 2010 80 11 1613 1631 2-s2.0-77957909450 10.1016/j.bcp.2010.07.043
24. Anderson S. L., Qiu J., Rubin B. Y., EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia. Biochemical and Biophysical Research Communications 2003 310 2 627 633 2-s2.0-0141681935 10.1016/j.bbrc.2003.09.019 (Pubitemid 37163710)
25. Anderson S. L., Qiu J., Rubin B. Y., Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia. Biochemical and Biophysical Research Communications 2003 306 1 303 309 2-s2.0-0038392607 10.1016/S0006-291X(03)00971-9 (Pubitemid 36629442)
26. Nakamura H., Furukawa F., Nishikawa A., Miyauchi M., Son H.-., Imazawa T., Hirose M., Oral toxicity of a tocotrienol preparation in rats. Food and Chemical Toxicology 2001 39 8 799 805 2-s2.0-0034969060 10.1016/S0278-6915(01) 00025-4 (Pubitemid 32575247)
27. Tasaki M., Umemura T., Inoue T., Okamura T., Kuroiwa Y., Ishii Y., Maeda M., Hirose M., Nishikawa A., Induction of characteristic hepatocyte proliferative lesion with dietary exposure of Wistar Hannover rats to tocotrienol for 1 year. Toxicology 2008 250 2-3 143 150 2-s2.0-49849083819 10.1016/j.tox.2008.07.003
28. Chomczynski P., Sacchi N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1987 162 1 156 159 2-s2.0-0023277545 (Pubitemid 17064313)
29. Abruzzo P. M., Di Tullio S., Marchionni C., Belia S., Fanó G., Zampieri S., Carraro U., Kern H., Sgarbi G., Lenaz G., Marini M., Oxidative stress in the denervated muscle. Free Radical Research 2010 44 5 563 576 2-s2.0-77951289481 10.3109/10715761003692487
30. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
31. Pfaffl M. W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 2001 29 9, article e45 2-s2.0-17344392308
32. Eswar N., Webb B., Marti-Renom M. A., Madhusudhan M. S., Eramian D., Shen M., Pieper U., Sali A., Comparative protein structure modeling using Modeller. Current Protocols in Bioinformatics 2006 5 5.6 2-s2.0-43749107283
33. Laskowski R. A., MacArthur M. W., Moss D. S., Thornton J. M., PROCHECK: a program to check the stereochemical quality of protein structures. Journal of Applied Crystallography 1993 26 part 2 283 291 10.1107/S0021889892009944
34. Sippl M. J., Recognition of errors in three-dimensional structures of proteins. Proteins 1993 17 4 355 362 2-s2.0-0027490731 10.1002/prot.340170404 (Pubitemid 23358545)
35. Shi R., Proteau A., Villarroya M., Moukadiri I., Zhang L., Trempe J., Matte A., Armengod E. E., Cygler M., Structural basis for Fe-S cluster assembly and tRNA thiolation mediated by IscS protein-protein interactions. PLoS Biology 2010 8 4 e1000354 2-s2.0-77951749014 10.1371/journal.pbio.1000354
36. Morris G. M., Huey R., Lindstrom W., Sanner M. F., Belew R. K., Goodsell D. S., Olson A. J., Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. Journal of Computational Chemistry 2009 30 16 2785 2791 2-s2.0-70349932423 10.1002/jcc.21256
37. Leidgens S., de Smet S., Foury F., Frataxin interacts with Isu1 through a conserved tryptophan in its β -sheet. Human Molecular Genetics 2009 19 2 276 286 2-s2.0-77949440735 10.1093/hmg/ddp495 ddp495
38. Armstrong J. S., Khdour O., Hecht S. M., Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question. The FASEB Journal 2010 24 7 2152 2163 2-s2.0-77954447250 10.1096/fj.09-143222
39. Marmolino D., Friedreich's ataxia: past, present and future. Brain Research Reviews 2011 67 1-2 311 330 2-s2.0-79957959532 10.1016/j.brainresrev. 2011.04.001
40. Marmolino D., Acquaviva F., Pinelli M., Monticelli A., Castaldo I., Filla A., Cocozza S., PPAR- γ agonist azelaoyl PAF increases frataxin protein and mRNA expression. New implications for the friedreich's ataxia therapy. Cerebellum 2009 8 2 98 103 2-s2.0-67949124861 10.1007/s12311-008-0087-z
41. Fang F., Kang Z., Wong C., Vitamin E tocotrienols improve insulin sensitivity through activating peroxisome proliferator-activated receptors. Molecular Nutrition and Food Research 2010 54 3 345 352 2-s2.0-77649303444 10.1002/mnfr.200900119
42. Li K., Singh A., Crooks D. R., Dai X., Cong Z., Pan L., Ha D., Rouault T. A., Expression of human frataxin is regulated by transcription factors SRF and TFAP2. PLoS ONE 2010 5 8 2-s2.0-77957921465 10.1371/journal.pone.0012286 e12286